Clinical trial data showed that lifileucel was efficacious in treating mucosal melanoma that progressed on immunotherapy. Lifileucel led to improvements in ...

Treatment of Trodelvy (sacituzumab govitecan-hziy) led to durable antitumor activity with predominant gastrointestinal toxicities in patients with ...

Dr Elise Rees is postdoctoral scientist in Professor Kwee Yong’s Multiple Myeloma Laboratory at the UCL Cancer Institute, and co-investigator on a ...

One dreary day after finishing a long day of Taxol chemo in 2018, I came home to a package addressed to me from HallieStrong. I did not recognize them name ...

Dr. Kiran Nandalur (left), a radiologist with Corewell Health and principal investigator of a new study that could help predict radiation side effects for ...

Last week, the European Society of Medical Oncology (EMSO) held their annual Congress in Madrid. The conference brought together cancer researchers from ...

tThe FDA approved two Loqorz-based regimens for patients with nasopharyngeal carcinoma. The Food and Drug Administration (FDA) approved Loqtorz ...

Patients with myeloproliferative neoplasms (MPNs) — blood cancers that cause the bone marrow to overproducer red or white blood cells or platelets, ...

Jemperli plus chemotherapy improved objective response rate and overall survival in patients with nonsquamous non-small cell lung cancer. Patients with ...

Patients with recurrent ovarian cancer (ROC) did not experience better outcomes when receiving maintenance therapy with immunotherapy Tecentriq ...

The use of post-surgical (adjuvant) Libtayo (cemiplimab)in patients with resectable stage 2-4 cutaneous squamous cell carcinoma (CSCC) showed a survival ...

Patients with metastatic HER2-positive gastric or gastroesophageal junction cancer saw improvements in progression-free survival with the addition of ...